15 completed, 4 unknown, 3 not yet recruiting, 3 terminated. 30 Phase 1, 13 Phase 2.
Follow Puerperal Disorders: new trials by email Literature Review of Puerperal Disorders trials Research Report on Puerperal Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis Tocilizumab - Granulomatous Lobular Mastitis, Granulomatous Mastitis | Phase 1 / Phase 2 | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 31 | 2026-06-01 | 2026-05-19 |
| Antibiotics vs Corticosteroids in Treatment of Granulomatous Lobular Mastitis Steroid, Antibiotic - Granulomatous Mastitis | Phase 1 / Phase 2 | Not yet recruiting | All India Institute of Medical Sciences, Bhubaneswar | 72 | 2026-03-15 | 2026-03-06 |
| ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS Tranexamic Acid (TXA), Placebo - Post Partum Hemorrhage | Phase 1 | Not yet recruiting | Patel Hospital, Pakistan | 104 | 2025-06-01 | 2025-06-04 |
| Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone Trazodone, Placebo - Postpartum Depression | Phase 1 | Withdrawn | Verinder Sharma | 2025-04-17 | 2025-04-04 | |
| Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery Ketamine (Ketalar) - Pain, Postpartum Depression | Phase 1 | Recruiting | University of Utah | 50 | 2025-03-28 | 2026-10-02 |
| Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1) Ketamine (Ketalar) Dose Level 1, Ketamine (Ketalar) Dose Level 2, Ketamine (Ketalar) Dose Level 3 - Pain, Postoperative, Depression, Postpartum | Phase 1 | Completed | Grace Lim, MD, MS | 12 | 2023-09-25 | 2025-09-12 |
| A Study on the Safety, Pharmacokinetics, and Food Effects of MI078 Capsules MI078, Placebo - Postpartum Depression | Phase 1 | Completed | Nanjing Minova Pharmaceutical Co., Ltd. | 98 | 2023-09-09 | 2025-05-21 |
| Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women Carbetocin 100 Microgram/mL Solution for Injection - Obesity, Maternal, Post Partum Hemorrhage | Phase 1 / Phase 2 | Completed | Cairo University | 150 | 2023-07-06 | 2024-01-22 |
| A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects Carbetocin, Placebo, Placebo and Moxifloxacin - Postpartum Hemorrhage | Phase 1 | Completed | Ferring Pharmaceuticals | 40 | 2023-05-25 | 2024-09-03 |
| A Study of BRII-297 in Healthy Adult Subjects BRII-297, Placebo - Postpartum Depression | Phase 1 | Completed | Brii Biosciences Limited | 41 | 2023-05-15 | 2024-01-18 |
| The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression Quetiapine - Postpartum Depression | Phase 1 | Active not recruiting | Verinder Sharma | 22 | 2022-03-18 | 2025-03-05 |
| Comparative Study Between the Roles of Intrauterine Misoprostol Versus the Sublingual Route for Prevention of Postpartum Blood Loss in Elective Cesarean Sections Misoprostol - Postpartum Hemorrhage | Phase 1 | Completed | Cairo University | 192 | 2022-01-01 | 2024-04-15 |
| Maternal Mental Health Trial Transdermal patch estradiol, Transdermal patch placebo - Major Depressive Disorder, Postpartum Depression | Phase 1 / Phase 2 | Recruiting | Vibe G Frøkjær, MD, PhD | 220 | 2021-02-03 | 2021-09-23 |
| A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH) fibrinogen concentrate, Placebo - Postpartum Hemorrhage | Phase 1 / Phase 2 | Withdrawn | Yale University | 2021-01-01 | 2021-03-15 | |
| Tranexamic Acid for the Prevention of Postpartum Haemorrhage Tranexamic Acid 100 milligram/Milliliter, Oxytocin - Postpartum Hemorrhage | Phase 1 / Phase 2 | Unknown | Benha University | 60 | 2020-01-01 | 2021-01-13 |
| Efficacy of Ginger Extract (Compare Between the Ginger Preparation of Ancient Concept of Thai Traditional Practitioner, Standard Drug and Placebo) by Using Pain Score to Evaluate After Pain of Three Groups of First Normal Postpartum Women. Ginger, Placebo oral capsule, Paracetamol - Postpartum Disorder | Phase 1 / Phase 2 | Completed | Thammasat University | 99 | 2018-08-29 | 2019-05-29 |
| Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility Oxytocin - Post Partum Haemorrhage | Phase 1 | Terminated | Oxytone Bioscience BV | 4 | 2018-04-03 | 2019-11-22 |
| Comparison of Inhaled Oxytocin (IH) With Intramuscular (IM) Oxytocin in Pregnant Women and With Intravenous (IV) Oxytocin in Healthy Non-pregnant Women IH Oxytocin, IM Oxytocin, IV Oxytocin - Postpartum Hemorrhage | Phase 1 | Terminated | GlaxoSmithKline | 31 | 2016-11-23 | 2020-03-23 |
| Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH Tranexamic Acid and Ethamsylate - Postpartum Hemorrhage | Phase 1 / Phase 2 | Unknown | Ahmed Alanwar | 64 | 2015-11-01 | 2015-11-30 |
| Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers IM oxytocin 10 IU, IH oxytocin 50 mcg, IH oxytocin 200 mcg - Postpartum Hemorrhage | Phase 1 | Completed | GlaxoSmithKline | 16 | 2015-09-14 | 2017-10-19 |
Showing 20 of 30. Sign in to see all of them.
Postpartum Hemorrhage (15) · Depression, Postpartum (10) · Depressive Disorder, Major (2) · Granulomatous Mastitis (2) · Pain (2) · Depression (1) · Mastitis (1) · Pain, Postoperative (1) · Pregnancy in Obesity (1) · Thrombosis (1)
Female Urogenital Diseases and Pregnancy Complications (30) · Pregnancy Complications (30) · Urogenital Diseases (30) · Pathological Conditions, Signs and Symptoms (17) · Pathologic Processes (16) · Hemorrhage (15) · Obstetric Labor Complications (15) · Uterine Hemorrhage (15) · Depressive Disorder (10) · Mental Disorders (10) · Mood Disorders (10) · Signs and Symptoms (4) · Breast Diseases (3) · Neurologic Manifestations (3)
Oxytocin (6) · Misoprostol (3) · Ketamine (2) · Sodium Chloride (2) · Tranexamic Acid (2) · Acetaminophen (1) · Anti-Bacterial Agents (1) · Control Groups (1) · Ethamsylate (1) · Excipients (1) · Fibrinogen (1) · Injections (1) · Melatonin (1) · Moxifloxacin (1) · Prednisolone (1)
Butler Hospital (2) · Cairo University (2) · GlaxoSmithKline (2) · Qazvin University Of Medical Sciences (2) · Verinder Sharma (2) · Ahmed Alanwar (1) · Ain Shams University (1) · Al-Azhar University (1) · All India Institute of Medical Sciences, Bhubaneswar (1) · Benha University (1) · Brii Biosciences Limited (1) · Ferring Pharmaceuticals (1) · Grace Lim, MD, MS (1) · Hormozgan University of Medical Sciences (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1)
United States (6) · Egypt (4) · Australia (3) · Iran (3) · Canada (2) · United Kingdom (2) · Bangladesh (1) · China (1) · Denmark (1) · India (1) · Pakistan (1) · Spain (1) · Sweden (1) · Thailand (1)
Grace Lim, MD, MSc (2) · Verinder Sharma, MB (2) · Abubaker M Elnashar, MD (1) · Aminur Rahman, MBBS,MSc (1) · Arunporn Itharat, PH.D. (1) · Brian G. Danaher, PhD (1) · Caron Zlotnick, PhD (1) · Jeannette Milgrom, PhD (1) · Juan M Rodriguez, PhD (1) · Mahmoud Edessy, prof (1) · Michael J Paidas, MD (1) · Minoo Rajaei, Dr (1) · Muhamed Osman Osman (1)
PMID 10467792, PMID 10908457, PMID 11502292, PMID 14600674, PMID 15954876, PMID 16581405, PMID 16842791, PMID 17197859, PMID 17634155, PMID 19432563, PMID 19943825, PMID 20009308, PMID 22540529, PMID 22882240, PMID 24191345, PMID 24734184, PMID 26611780, PMID 28781129, PMID 31598047, PMID 32609374, PMID 32987448, PMID 33078388, PMID 35763351, PMID 37485589, PMID 37522415, PMID 39472831, PMID 42802704
R01MH134538 (2), 2016 (1), R01MH084931 (1), R21MH061555 (1), R34MH075013 (1)